Specialty CRO Agility Clinical is formed

Thursday, May 31, 2012 02:36 PM

David F. Hale, chairman and CEO of Hale BioPharma Ventures, has founded a new CRO, Agility Clinical, in Carlsbad, Calif.

The CRO will focus on providing customized clinical research and consulting services to small and virtual biotechnology, specialty pharma, medical device and diagnostic companies. 

"Agility's mission is to provide services to small and virtual biopharma companies, with a focus on treatments or diagnoses for children and orphan diseases,” said Hale. “While Agility will provide traditional CRO services, companies may also choose from a menu of services that addresses their specific needs.”

Hale, who has been involved in the Southern California life sciences industry for over 25 years, has been involved as founder, CEO or chairman of several companies, including Hybritech, Gensia, Viagene, Santarus, Somaxon Pharmaceuticals, SkinMedica and Neurelis.  Hale will serve as Agility Clinical’s chairman of the board and has recruited an executive management team of industry veterans who have significant experience in the design, execution and completion of clinical trials, including Ellen Morgan, Marilyn Carlson, DMD, MD, Elizabeth Ludington, PhD, Kristi Clark, MBA, and Ali Sadighian.

Morgan, who will serve as CEO, brings 30 years of industry experience to Agility Clinical. She was co-founder, CEO and chairman of Synteract, a California-based CRO which grew to over 300 employees, and provided clinical services to hundreds of companies. She is also founder and CEO of the first non-profit CRO, Public Health Alliance for Clinical Trials (PHACT), whose mission is to conduct clinical trials for neglected diseases in developing countries.

"The name Agility Clinical was chosen to reflect our corporate culture and mission.  Small and virtual companies need service providers that are agile, affordable, experienced and dedicated," said Morgan. "Agility will provide exceptional service while keeping costs reasonable. At Agility, we will not only be able to support biopharma with the expertise and dedication they require, but our focus on pediatric and orphan drug studies will help the patients with the greatest need."

Share:          
CWWeekly

April 20

Christie Clinic, PMG Research's 12th clinical research site, expands its geographic reach north to Illinois

Clinipace acquires Accovion to expand European presence, following an infusion of equity that could lead to more deals

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs